CGEN vs IPHA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 21, 2026
CGEN
IPHA
Investment Advisor Scores
IPHA
Oct 21, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | CGEN | IPHA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.3609 | 0 | Tie |
| PEG Ratio | 1.2874 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 107.0% | 16.5% | CGEN |
| Earnings Growth | 0.0% | -74.7% | CGEN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 63.3/100 | 63.7/100 | IPHA |
| Profit Margin | 47.6% | 0.0% | CGEN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | STRONG BUY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CGEN
MarkdownPrice below a falling SMA50 (slope -3.1%), weak momentum, RSI 36
IPHA
MarkdownPrice below a falling SMA50 (slope -5.9%), weak momentum, RSI 41
Fundamentals Snapshot
| Metric | CGEN | IPHA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -5.3 | -3.2 |
| Trailing P/E | 5.6 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 1.1% | 0.2% |
| Gross Margin | 0.9% | -3.1% |
| Operating Margin | -3.4% | -3.4% |
| EPS | 0.38 | -0.59 |
| Dividend Yield | — | — |